Q4 Investment Playbooks: What Top Analysts Say - TheStreet

NEW YORK (TheStreet) --With September coming to an end on Friday, the "Fast Money Halftime Report" panel on CNBC discussed their investment playbooks for the final three months of the year.

"I really like biotech I think you can short either pharma or software against it. If you want to short growth do software, if you want to short the yield play its pharma," Morgan Stanley chief U.S. equity strategist Adam Parker noted.

UBS Wealth Management managing director Robert Sechan explained why emerging markets is a key part of his playbook for the rest of the year.

"We like emerging markets from a valuation perspective. If you believe in the cyclical recovery you have to think that emerging markets are going to do well in an environment of abundant illiquidity, low U.S. rates, and commodity prices recovering," he explained.

Lebenthal Asset Management CEO Jim Lebenthal said investors should pay attention to the brick and mortars moving into the end of 2016.

"On a more dangerous [trade], but a lot more upside, you could take a look at bricks and mortar retail. This is the time of year where some people get a little but more enthusiastic, usually these stocks build into Black Friday after Thanksgiving, and then they trail off," he said.

Short Hills Capital CIO Stephen Weiss feels longer duration investments are the best play and is particularly bullish on one stock.

"I really like Orbital ATK (OA)  they had an accounting issue, a small one, but they keep saying they're going to file. Once they get up to speed with their filing in October that stock will go back up to $90," he noted.